Literature DB >> 19846573

ERK5 activation enhances mesangial cell viability and collagen matrix accumulation in rat progressive glomerulonephritis.

Maki Urushihara1, Masanori Takamatsu, Maki Shimizu, Shuji Kondo, Yukiko Kinoshita, Kenichi Suga, Akiko Kitamura, Sato Matsuura, Masanori Yoshizumi, Toshiaki Tamaki, Hiroshi Kawachi, Shoji Kagami.   

Abstract

The mitogen-activated protein kinase (MAPK) cascade plays an important role in the regulation of various cellular functions in glomerulonephritis (GN). Here, we investigated whether extracellular signal-regulated kinase 5 (ERK5), a member of the MAPK family, is involved in the pathogenesis of chronic mesangioproliferative GN, using a rat model induced by uninephrectomy and anti-Thy-1 antibody injection. Immunostaining of kidneys obtained at different time points revealed that phospho-ERK5 was weakly expressed in control glomeruli but dramatically increased in a typical mesangial pattern after 28 and 56 days of GN. A semiquantitative assessment indicated that glomerular phospho-ERK5 expression closely paralleled the accumulation of extracellular matrix (ECM), collagen type I, as well as glomerular expression of reactive oxygen species (ROS) and ANG II. On the other hand, phospho-ERK1/2 expression increased on day 7 during the phase of enhanced mesangial cell (MC) proliferation and decreased thereafter. H(2)O(2) and ANG II each induced ERK5 phosphorylation by cultured rat MCs. Costimulation with both H(2)O(2) and ANG II synergistically increased ERK5 phosphorylation in MCs. Cultured MCs transfected with ERK5-specific small interference RNA showed a significant decrease in H(2)O(2) or ANG II-induced cell viability and soluble collagen secretion compared with control cells. Treatment of GN rats with an ANG II type 1 receptor blocker resulted in significant decreases in phospho-ERK5 expression and collagen accumulation accompanied by remarkable histological improvement. Taken together, these results suggest that MC ERK5 phosphorylation by ANG II or H(2)O(2) enhances cell viability and ECM accumulation in an experimental model of chronic GN.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19846573     DOI: 10.1152/ajprenal.00124.2009

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  13 in total

1.  Rho-kinase/nuclear factor-κβ/angiotensinogen axis in angiotensin II-induced renal injury.

Authors:  Hiroyuki Kobori; Yuri Ozawa; Omar W Acres; Kayoko Miyata; Ryousuke Satou
Journal:  Hypertens Res       Date:  2011-06-02       Impact factor: 3.872

2.  Extracellular-regulated-kinase 5-mediated renal protection against ischemia-reperfusion injury.

Authors:  Tomoko Kawakami; Sang Won Park; Ryuji Kaku; Jay Yang
Journal:  Biochem Biophys Res Commun       Date:  2012-01-24       Impact factor: 3.575

3.  Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis.

Authors:  Maki Urushihara; Naro Ohashi; Kayoko Miyata; Ryousuke Satou; Omar W Acres; Hiroyuki Kobori
Journal:  Hypertension       Date:  2011-01-31       Impact factor: 10.190

4.  A positive feedback loop involving Erk5 and Akt turns on mesangial cell proliferation in response to PDGF.

Authors:  Amit Bera; Falguni Das; Nandini Ghosh-Choudhury; Xiaonan Li; Sanjay Pal; Yves Gorin; Balakuntalam S Kasinath; Hanna E Abboud; Goutam Ghosh Choudhury
Journal:  Am J Physiol Cell Physiol       Date:  2014-04-16       Impact factor: 4.249

5.  Glomerular angiotensinogen is induced in mesangial cells in diabetic rats via reactive oxygen species--ERK/JNK pathways.

Authors:  Naro Ohashi; Maki Urushihara; Ryousuke Satou; Hiroyuki Kobori
Journal:  Hypertens Res       Date:  2010-08-05       Impact factor: 3.872

6.  Mechanisms of Cardiorenal Protection With SGLT2 Inhibitors in Patients With T2DM Based on Network Pharmacology.

Authors:  Anzhu Wang; Zhendong Li; Sun Zhuo; Feng Gao; Hongwei Zhang; Zhibo Zhang; Gaocan Ren; Xiaochang Ma
Journal:  Front Cardiovasc Med       Date:  2022-05-23

Review 7.  Role of the intrarenal renin-angiotensin system in the progression of renal disease.

Authors:  Maki Urushihara; Shoji Kagami
Journal:  Pediatr Nephrol       Date:  2016-07-05       Impact factor: 3.714

Review 8.  Involvement of glomerular renin-angiotensin system (RAS) activation in the development and progression of glomerular injury.

Authors:  Shoji Kagami
Journal:  Clin Exp Nephrol       Date:  2011-12-02       Impact factor: 2.801

Review 9.  Involvement of the intrarenal renin-angiotensin system in experimental models of glomerulonephritis.

Authors:  Maki Urushihara; Yukiko Kinoshita; Shuji Kondo; Shoji Kagami
Journal:  J Biomed Biotechnol       Date:  2012-07-02

10.  Hydrogen peroxide-inducible clone-5 regulates mesangial cell proliferation in proliferative glomerulonephritis in mice.

Authors:  Ariunbold Jamba; Shuji Kondo; Maki Urushihara; Takashi Nagai; Joo-Ri Kim-Kaneyama; Akira Miyazaki; Shoji Kagami
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.